英夫利西单抗对溃疡性结肠炎模型大鼠的治疗作用

Therapeutic effect of infliximab on ulcerative colitis model of rat

  • 摘要: 目的 观察英夫利西单抗对溃疡性结肠炎(UC)模型大鼠的治疗机制。方法 选取48只成年Wistar大鼠随机分成正常组、英夫利西单抗低、中、高剂量组、美沙拉秦组和模型组,每组8只,建立大鼠UC模型,英夫利西单抗低剂量给予2.5mg/kg,中剂量给予5mg/kg,高剂量给予10mg/kg,皮下注射,第1、7日给药,美沙拉秦组给予100mg/kg,每日给药。造模两周后,眼球取血1.5mL,ELISA检测各组大鼠TNF-α、IL-8。结果 UC模型大鼠TNF-α、IL-8含量显著降低(P<0.05)。结论 英夫利西单抗对UC模型大鼠有较好的治疗作用。

     

    Abstract: Objective To observe the effect of infliximab on ulcerative colitis(UC)model of rat. Methods Forty-eight healthy adult Wistar rats were selected and divided randomly into normal group,low infliximab dose group,medium infliximab dose group,high infliximab dose group mesalazine group and model group(n=8).A UC model of rat was established by subcutaneous injection of infliximab at the doses of 2.5mg/kg,5mg/kg and 10mg/kg,respectively,on days 1 and 7.Rats in mesalazine group received intra-gastric mesalazine,100mg/kg body weight,once a day.Two weeks after establishment of the model,1.5mL blood was collected from fossa orbitalis to detect TNF-αand IL-8 by ELISA. Results The TNF-αand IL-8 expression levels were significantly decreased in the UC model. Conclusion Infliximab has rather good therapeutic effects in UC model of rats.

     

/

返回文章
返回